Michelle Johnson Armistead, SLP | |
705 17th St Ste 407, Columbus, GA 31901-3514 | |
(706) 321-0930 | |
(706) 571-0960 |
Full Name | Michelle Johnson Armistead |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 705 17th St Ste 407, Columbus, Georgia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205398377 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 3942 (Alabama) | Secondary |
235Z00000X | Speech-language Pathologist | SLP010367 (Georgia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Michelle Johnson Armistead, SLP 704 Mcdonald Dr, Opelika, AL 36801-3452 Ph: (251) 209-2068 | Michelle Johnson Armistead, SLP 705 17th St Ste 407, Columbus, GA 31901-3514 Ph: (706) 321-0930 |
News Archive
Teva Women's Health, a U.S. subsidiary of Teva Pharmaceutical Industries Ltd., today announced that the recently approved Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) tablets are now available via prescription in the U.S. for the prevention of pregnancy.
In a study published in Annals of Internal Medicine, researchers from Italy systematically monitored 2,397 HCWs who were fully vaccinated with BNT162 at the ASST Settelaghi hospitals in Lombardy, Italy during February 2021. HCWs who worked in 8 wards deemed at "high risk" for infection from attending patients had to undergo mandatory nasopharyngeal swab testing with SARS-CoV-2 polymerase chain reaction every two weeks. HCWs working in 8 "moderate-risk" wards were tested every four weeks.
An Australian-owned obesity drug, developed by Melbourne-based biotechnology company Metabolic Pharmaceuticals Limited, is set to enter final human trials next year after successfully completing a Phase 2b human trial which proved that the drug induces weight loss and is very well tolerated with no evidence of the side effects commonly experienced with existing obesity drugs.
Recapping the 30-year history of HIV/AIDS from an USAID perspective, Administrator Rajiv Shah writes in this "Impact blog" post, "Our work is far from done. We have a shared responsibility as a global partner to save lives by focusing on smart investments. The generosity of the American people has made sustained progress against this deadly disease possible. Closing the chapter on HIV/AIDS will require a steadfast focus on remaining gaps and challenges as we chart the way forward".
One of the most obvious changes that comes with aging is that people start doing things more slowly. Numerous studies have shown that aging also affects language processing.
› Verified 1 days ago
Brittni Irene Dickenson, MED-CSD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2424 Double Churches Rd, Columbus, GA 31909 Phone: 706-324-6112 Fax: 706-596-8259 | |
Lori Sprayberry Morgan, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2424 Double Churches Rd, Columbus, GA 31909 Phone: 706-324-6112 Fax: 706-596-8259 | |
Procom Speech-language Services Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3645 Gentian Blvd Ste 3b, Columbus, GA 31907 Phone: 706-457-3883 Fax: 706-243-4985 | |
Allison Shannon Ganus, MCD CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2424 Double Churches Rd, Columbus, GA 31909 Phone: 706-324-6112 Fax: 706-596-8259 | |
Joanna Boone Caldwell, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 705 17th St, Suite 407, Columbus, GA 31901 Phone: 706-321-0930 | |
Heather Neely, M.S., CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2515 Double Churches Rd, Columbus, GA 31909 Phone: 706-660-5495 | |
Natalie Njotu, MS.CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1555 Doubletree Dr, Columbus, GA 31904 Phone: 706-406-4088 |